Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Inc. (TELO)

Market Open
12 Jun, 15:17
NASDAQ (CM) NASDAQ (CM)
$
1. 30
+0.04
+3.5714%
$
43.66M Market Cap
- P/E Ratio
- Div Yield
47,374 Volume
- Eps
$ 1.26
Previous Close
Investors:
Add Transaction
Day Range
1.25 1.31
Year Range
1.05 3.1
Want to track TELO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
3 Jun 2026
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
12 May 2026
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
10 Mar 2026
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
3 Feb 2026
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
11 Nov 2025
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
11 Aug 2025
-
-
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
26 Feb 2025
-
-

TELO Earnings Reports FAQ

What is the earnings per share (EPS) for TELO?

EPS data for TELO is currently not available, as Telomir Pharmaceuticals Inc has not reported recent earnings.

What is the company's earnings growth rate?

Telomir Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Telomir Pharmaceuticals Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Telomir Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for TELO at this time, as Telomir Pharmaceuticals Inc has no recent EPS data to calculate it.